Sort
8,912 grants matching “sars cov 2”
Improving Glycemia & Reducing Diabetes Distress in Adolescents & Young Adults with T1D
$119,527Lori M Laffel · Joslin Diabetes Center · R01 · FY2024 · DK
Improving Glycemia & Reducing Diabetes Distress in Adolescents & Young Adults with T1D
$119,469Lori M Laffel · Joslin Diabetes Center · R01 · FY2023 · DK
Investigating the role of Alpha5Beta1 integrin in cognitive dysfunction
$119,115Gregory Jaye Bix · Tulane University Of Louisiana · RF1 · FY2024 · AG
Pattern Identification in Sequence Activity Data
$119,097Vipul Periwal · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Inferring epidemic characteristics with networks
$119,097Vipul Periwal · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Innovating acute care for liver disease through a pilot, patient-centric Hospital@Home program
$118,695Archita P. Desai · Indiana University Indianapolis · R03 · FY2025 · DK
Community-engaged research to promote SARS-CoV-2 vaccine uptake in Montanas American Indian and rural communities
$118,422Curtis William Noonan · University Of Montana · P20 · FY2022 · GM
Characterization of replication and transcription of SARS-CoV-2
$117,987Wei Yang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Northwell Health NCORP
$117,905Vincent P Vinciguerra · Feinstein Institute For Medical Research · UG1 · FY2022 · CA
COVID Surveillance in South Dakota Wastewater and Clinical Samples
$117,839Victor Chester Huber · University Of South Dakota · P20 · FY2022 · GM
Methods for the study of polydisperse ribonucleoprotein complexes
$117,449Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2025 · EB
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$117,308Shabaana A. Khader · Washington University · R01 · FY2020 · AI
COVID-19: NIAID SPECIMEN REPOSITORY
$117,253Deborah Phippard · Precision Bioservices, Inc. · N01 · FY2020 · AI
COVID-19: NIAID SPECIMEN REPOSITORY
$117,253Deborah Phippard · Precision Bioservices, Inc. · N01 · FY2021 · AI
Antibody display libraries for precision screening of antibody immune responses to SARS-CoV-2
$117,244Brandon James Dekosky · Massachusetts General Hospital · DP5 · FY2022 · OD
Scientific Project 3: Covid Immune response to SARS-CoV-2 natural infection followed by vaccination
$117,223Gregory Lee Szeto · Seattle Children'S Hospital · U19 · FY2023 · AI
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
$117,120David A. Zidar · Case Western Reserve University · U01 · FY2022 · CA
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease
$116,998Degui Zhi · University Of Texas Hlth Sci Ctr Houston · U01 · FY2022 · AG
Synergistic integration of topology and machine learning for the predictions of protein-ligand binding affinities and mutation impacts
$116,389Guowei Wei · Michigan State University · R01 · FY2020 · GM
RAPID: Prediction of coronavirus infections and complications at the individual and the population levels from genomic, proteomic, clinical and behavioral data sources
$116,000Judith Klein · Colorado School Of Mines · · FY2020 · CSE
Insights into Sickle Cell Trait and Sickle Cell Disease
$115,613Vence L Bonham · National Human Genome Research Institute · ZIA · FY2025 · HG
Pathogen Discovery Through Longitudinal Serological Surveillance in ME/CFS
$115,586Nischay Mishra · Columbia University Health Sciences · U54 · FY2024 · NS
Regulation of B cell Responses in SLE and Other Autoimmune Diseases
$115,104Christopher D Scharer · Emory University · U19 · FY2025 · AI
Building testing capacity and sequencing capability for COVID-19 at Tifton Veterinary Diagnostic and Investigational Laboratory (TVDIL)
$115,077Yung-Yi Mosley · University Of Georgia · U18 · FY2021 · FD
Elucidating a novel respiratory-mammary axis of T cell immunity
$114,976Blair Armistead · Seattle Children'S Hospital · K99 · FY2025 · AI